Global AI in Neurology Market - Industry Trends and Forecast to 2031

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global AI in Neurology Market - Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Jan 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Ai In Neurology Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 48.00 Million
Diagram Market Size (Forecast Year)
USD 716.52 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global AI in Neurology Market, By Indication (Neuro-technology, Neurosurgery), Application (Screening & Diagnosis, Treatment, Research & Development, Training, Surgical Planning and Rehabilitation, Others), Type (Oncology, Neurodegeneration, Neurovascular, Traumatic Brain Injury, Spinal Cord Injury), Technology (Machine Learning and Deep Learning, Natural Language Processing [NLP], Others), Components (Hardware, Software-as-a-Service[SaaS]), End-User (Hospitals, Diagnosis Centers, Others) - Industry Trends and Forecast to 2031.

AI in Neurology Market

AI in Neurology Market Analysis and Size

AI can help improve the diagnosis and detection of brain tumors and other neurological cancers with high accuracy and consistency. Studies show that optical imaging and deep convolutional neural networks (CNNs) can be used to accurately predict brain tumors in less than 150 seconds. AI can also help overcome current industry challenges in the field of neurology by enabling higher efficiency, accuracy, and better patient care. In addition, AI can simulate and access in-depth data about the process of impulse formation and transfer throughout the body, which can help neurologists provide personalized treatments.

Data Bridge Market Research analyzes that the global AI in neurology market, which was USD 48.00 million in 2023, is likely to reach USD 716.52 million by 2031 and is expected to undergo a CAGR of 40.2% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Indication (Neuro-technology, Neurosurgery), Application (Screening & Diagnosis, Treatment, Research & Development, Training, Surgical Planning and Rehabilitation, Others), Type (Oncology, Neurodegeneration, Neurovascular, Traumatic Brain Injury, Spinal Cord Injury), Technology (Machine Learning and Deep Learning, Natural Language Processing [NLP], Others), Components (Hardware, Software-as-a-Service[SaaS]), End-User (Hospitals, Diagnosis Centers, Others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America

Market Players Covered

ActivSurgical Inc. (U.S.), Brainomix Limited (U.K.), Caresyntax Corp (U.S.), Neosama Inc. (Israel), ExplORer Surgical Corp. (U.S.), Surgalign Spine Technology Inc. (U.S.), LeanTaaS Inc. (U.S.), Medtronic Plc (Ireland), Scalpel Limited (U.K.), and Theator Inc. (U.S.)

Market Opportunities

 

  • Growing demand for software-as-a-service (SaaS) in AI neurology
  • Increasing research and development activities

Market Definition

The AI (Artificial Intelligence) in neurology market is the application of artificial intelligence and machine learning technologies in the field of neurology. This market encompasses the development and utilization of AI tools, software, and hardware solutions that assist healthcare professionals, particularly neurologists and neurosurgeons, in diagnosing, treating, and managing neurological conditions. AI in neurology involves the use of advanced algorithms, neural networks, and computational techniques to analyze and interpret complex neurological data, such as brain imaging scans, patient records, and clinical data, to improve patient care and outcomes.

Global AI in Neurology Market Dynamics

Drivers

  • Increased data availability0

With the growing use of digital healthcare records, medical imaging, and wearable devices, there is a vast amount of neurological data available. AI can efficiently process and analyze this data, making it an attractive tool for neurologists and researchers to gain insights into neurological conditions. This data-driven approach can lead to more accurate diagnoses and treatment recommendations.

  • Shortage of neurologists

Many regions face a shortage of neurologists, which can lead to delayed diagnoses and treatment for patients with neurological disorders. AI tools can help bridge this gap by providing decision support to healthcare professionals, enabling them to make quicker and more informed decisions. This can be particularly important in emergency cases like strokes, where timely intervention is critical.

Opportunity

  • Advancements in AI algorithms

The development of advanced machine learning and deep learning algorithms has significantly improved the accuracy and capabilities of AI systems in diagnosing and managing neurological conditions. These algorithms can detect subtle patterns in medical images, genomics data, and clinical records that may be challenging for humans to identify.

Restraint/Challenge

  • Interoperability Challenges

Integrating AI systems with existing electronic health record (EHR) systems and hospital infrastructure can be challenging. Achieving seamless interoperability is essential for the effective use of AI in neurology, but compatibility issues and data exchange standards can be restraints.

Recent Developments

  • In 2023, Surgalign Spine Technologies, Inc. announced the release of Holo AI insights for neurovascular research to automatically segment medical images, measure anatomic structures, automate pedicle screw planning, and perform other tasks
  • In 2022, Neosoma Inc. announced to received FDA clearance for its first AI-based Neuro-Oncology Software, Neosoma HGG (High-Grade Glioma)

Global AI in Neurology Market Scope

The AI in neurology market is segmented on the basis of indication, application, type, technology, components, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

  • Neuro-technology
  • Neurosurgery

Application

  • Screening & Diagnosis
  • Treatment
  • Research & Development
  • Training
  • Surgical Planning and Rehabilitation
  • Others

Type

  • Oncology
  • Neurodegeneration
  • Neurovascular
  • Traumatic Brain Injury
  • Spinal Cord Injury

Technology

  • Machine Learning and Deep Learning
  • Natural Language Processing [NLP]
  • Others

End User

  • Hospitals
  • Diagnosis Centers
  • Others

Global AI in Neurology Market Regional Analysis/Insights

The AI in neurology market is analyzed and market size insights and trends are provided by country, indication, application, type, technology, components, and end user as referenced above.

The countries covered in the AI in neurology market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the presence of advanced healthcare infrastructure.

Asia-Pacific is expected to grow during the forecast period due to surge in regional investments.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The AI in neurology market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the AI in neurology market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the AI in neurology market.

Competitive Landscape and AI in Neurology Market Share Analysis

The AI in neurology market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the AI in neurology market.

Some of the major players operating in the AI in neurology market are:

  • ActivSurgical Inc. (U.S.)
  • Brainomix Limited (U.K.)
  • Caresyntax Corp (U.S.)
  • Neosama Inc. (Israel)
  • ExplORer Surgical Corp. (U.S.)
  • Surgalign Spine Technology Inc. (U.S.)
  • LeanTaaS Inc. (U.S.)
  • Medtronic Plc (Ireland)
  • Scalpel Limited (U.K.)
  • Theator Inc. (U.S.)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The AI in neurology market size will be worth USD 716.52 million by 2031.
The growth rate of the AI in neurology market is 40.2% in the forecast period by 2031.
Increased data availability and increased data availability are the growth drivers of the AI in neurology market.
indication, application, type, technology, components, and end-user are the factors on which the AI in neurology market research is based.
Major companies in the AI in neurology market are ActivSurgical Inc. (U.S.), Brainomix Limited (U.K.), Caresyntax Corp (U.S.), Neosama Inc. (Israel), ExplORer Surgical Corp. (U.S.), Surgalign Spine Technology Inc. (U.S.), LeanTaaS Inc. (U.S.), Medtronic Plc (Ireland), Scalpel Limited (U.K.), and Theator Inc. (U.S.).